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Rapid action by Chandigarh: Flew away the threat of bird flu
Dear Editor,
The peaceful life of the beautiful city, Chandigarh, was disrupted one December winter morning when the newspapers reported that one of the samples from a goose that had died at Sukhna Lake, tested positive for the deadly avian influenza virus (H5N1) at the National Institute of High Security Animal Diseases Laboratory, Bhopal. [1] This sample was tested owing to the spontaneous death of over 30 geese at the lake. The outbreak was attributed to the migratory birds. This is the first time that India has witnessed H5N1 outbreak among non-commercial captive geese. However, the rapid response team of the Chandigarh Administration came into action and was followed by the immediate culling of approximately 110 geese. [2] The centre issued a sanitisation certificate to the Chandigarh Administration as the immediate fear of the spread of infection was controlled. [2] All the school children who had visited the lake were followed up, schools within a radius of 3 km were closed and the lake was closed to the visitors. [3] An urgent response helped to contain the virus, which was further possible due to the ongoing preparedness in India in response to the high alert created due to the ongoing Ebola outbreak in Africa. Till date, no human infections have been reported in India, though worldwide a total of 676 confirmed human cases of H5N1 and 398 deaths have been reported. [4] Currently, the best way to prevent infection with avian influenza A viruses is to avoid sources of exposure whenever possible. For treatment (and prevention), oseltamivir or zanamivir is recommended. The stockpiled vaccine could be used if a H5N1 virus begins transmitting easily from person to person. A new recombinant A (H5N1) vaccine virus has been developed by the National Institute of Virology, Pune, India. H5N1 outbreak in Chandigarh was well controlled and Sukhna Lake was opened after 1-month. [5] Financial support and sponsorship Nil.
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• The authors have assessed the validity of DDST by detecting three beta-lactamase genes: blaCTX-M, blaTEM, and blaSHV by PCR and consider their presence in bacteria as the genetic basis for ESBL production. While all CTX-M genes code for ESBL, only 42% of TEM types and 25% of SHV types are currently known to code for ESBL phenotype.
[7] Thus, genetic validity for ESBL production cannot be inferred by mere detection of blaTEM or blaSHV genes. One needs to sequence further the entire length of the genes and confirm whether they are ESBL producing types or not.
[8]
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Dear Editor,
We read with interest the paper on detection of extended-spectrum beta-lactamase (ESBL) producing bacteria from patients with urinary tract infections published in the recent issue of IJMM. [1] We have three comments:
• The authors have used only ceftazidime/ceftazidime + clavulanic acid disks for screening. As per the CLSI guidelines, both ceftazidime and cefotaxime disks, alone and in combination with clavulanic acid must be used to detect ESBL production. [2] This is because of substrate variability; some ESBLs (e.g.TEM-5) are ceftazidimases and some others (e.g.TEM-3) are cefotaximases. [3] In a previous study, we had screened 1000 clinical isolates each of Escherichia coli and Klebsiella pneumoniae using both disks. [4] On further analysis of our study, we found that we would have missed 9.6% of ESBL producers if we had used only ceftazidime/ceftazidime + clavulanic acid disks. Thus, we recommend that all researchers should use both the combination disks as per CLSI recommendations • The authors have shown that the results of E-test correlate well with the results obtained by polymerase chain reaction (PCR). They recommend the E-test for confirmation of those detected as ESBL producers by the Double Disk Synergy Test (DDST). We would like to, however, add that E-test may not be an ideal confirmatory test for ESBL producers. There are reports that question the utility of E-test for detecting ESBLs as the concentration gradient in E-strip is not as extensive as recommended by CLSI and the test has been shown to yield many indeterminate results [5, 6] Detection of extended-spectrum beta-lactamases
